Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $96.66 | $23.18 | 316.98% | 210.13x | 161.99x | 13.13x | 16.26x | 1.49x | $119.79M | 1.19% | $637.99M | 6.11 | $10.28B | -1,496.87 | ||
| LQDA | LIQUIDIA CORP | $89.03 | $16.93 | 425.99% | 370.96x | 26.80x | 27.20x | 72.92x | 1.83x | $41.15M | 0.53% | $108.58M | 1.23 | $7.88B | 147.02 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.41 | $2.71 | 210.48% | 120.14x | 74.96x | 4.56x | 111.59x | 1.15x | $47.52M | 3.32% | $13.01M | 0.08 | $1.60B | 29.92 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $268.74 | $91.18 | 194.73% | 61.64x | 35.77x | 8.33x | 33.37x | 1.25x | $641.34M | 1.80% | $1.08B | 8.09 | $37.14B | 40.17 | ||
| KRYS | KRYSTAL BIOTECH INC | $327.50 | $91.20 | 259.10% | 42.26x | 42.21x | 22.99x | 7.56x | 2.03x | $237.38M | 2.47% | $1.28B | 43.59 | $9.16B | 42.82 | ||
| HALO | HALOZYME THERAPEUTICS INC | $80.84 | $68.45 | 18.10% | 27.31x | 9.73x | 6.33x | 43.66x | 0.49x | $667.65M | 6.99% | $219.64M | 1.86 | $11.42B | 18.31 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $63.05 | $16.63 | 279.23% | 64.34x | 49.39x | 6.40x | 8.01x | 1.74x | $164.23M | 3.40% | $605.69M | 7.92 | $4.67B | 41.89 | ||
| ADMA | ADMA BIOLOGICS INC | $8.37 | $8.83 | -5.23% | 12.13x | 9.98x | 3.88x | 4.97x | 0.51x | $107.90M | 5.46% | $390.33M | 1.65 | $2.00B | 9.03 | ||
| RPRX | ROYALTY PHARMA PLC | $59.02 | $38.98 | 51.39% | 30.90x | 11.00x | 10.56x | 3.42x | 0.65x | $2.34B | 9.08% | $9.94B | 22.75 | $42.36B | 36.41 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.87 | $37.59 | 56.60% | 42.05x | 15.94x | 3.50x | 1.83x | 0.62x | $767.06M | 6.77% | $6.21B | 32.27 | $9.74B | 20.18 | ||
| VCEL | VERICEL CORP | $45.05 | $8.77 | 413.65% | 104.76x | 93.43x | 7.83x | 6.46x | 2.20x | $47.49M | 2.08% | $356.23M | 7.02 | $2.29B | 56.55 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $302.15 | $94.42 | 220.01% | 38.25x | 32.99x | 21.89x | 6.07x | 1.79x | $122.22M | 2.03% | $997.32M | 50.16 | $6.39B | 28.34 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $254.87 | $47.25 | 439.35% | 542.28x | 9.84x | 3.55x | 3.53x | 1.83x | $1.30B | 8.23% | $4.53B | 73.22 | $19.55B | 28.96 | ||
| ASND | ASCENDIS PHARMA A | $252.66 | $77.12 | 227.61% | 26.78x | 17.37x | 15.41x | 27.34x | 2.77x | $52.94M | 0.34% | $574.09M | 9.24 | $16.07B | 172.37 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.80 | $34.24 | 4.55% | 14.15x | 9.52x | 2.30x | 2.28x | 0.54x | $341.79M | 16.51% | $910.35M | 15.75 | $1.64B | 6.93 | ||
| TECH | BIO-TECHNE CORP | $71.77 | $16.08 | 346.41% | 101.08x | 34.40x | 9.27x | 5.39x | 1.85x | $269.60M | 2.40% | $2.09B | 13.34 | $11.32B | 44.21 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.16 | $8.62 | -86.54% | 4.30x | -3.92x | 1.09x | 1.27x | 0.05x | $7.24M | 10.86% | $52.93M | 0.92 | $13.51M | 0.87 | ||
| TGTX | TG THERAPEUTICS INC | $55.50 | $20.91 | 165.40% | 17.24x | 39.32x | 11.45x | 14.57x | 3.87x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.80B | 58.69 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $473.09 | $160.12 | 195.47% | 27.81x | 24.46x | 9.84x | 6.20x | 2.06x | $3.71B | 3.09% | $19.36B | 76.20 | $116.57B | 21.61 | ||
| EXEL | EXELIXIS INC | $55.65 | $29.85 | 86.46% | 17.84x | 17.08x | 6.05x | 7.23x | 1.28x | $917.69M | 6.38% | $1.94B | 7.49 | $13.93B | 13.19 | ||
| UTHR | UNITED THERAPEUTICS CORP | $529.53 | $230.39 | 129.84% | 18.09x | 19.40x | 7.27x | 3.81x | 2.07x | $1.02B | 4.41% | $5.90B | 135.66 | $21.20B | 12.37 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.19 | $2.04 | 56.40% | 13.29x | 13.70x | 1.95x | 3.09x | 1.25x | $4.11M | 1.60% | $82.33M | 1.03 | $190.09M | 8.95 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $651.91 | $416.97 | 56.35% | 15.32x | 13.95x | 4.54x | 2.17x | 1.04x | $4.11B | 6.07% | $31.42B | 302.15 | $68.09B | 11.85 | ||
| VCYT | VERACYTE INC | $57.88 | $8.65 | 568.82% | 52.14x | 52.20x | 8.50x | 3.44x | 6.14x | $155.34M | 3.37% | $1.34B | 16.90 | $4.39B | 38.18 | ||
| INCY | INCYTE CORP | $116.69 | $63.29 | 84.37% | 16.01x | 14.64x | 4.34x | 4.15x | 1.42x | $1.45B | 6.24% | $5.62B | 28.21 | $19.88B | 10.63 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.